上市公司 Propanc Biopharma 计划收购 1 亿美元以太坊
ChainCatcher 消息，生物制药公司 Propanc Biopharma (纳斯达克股票代码: PPCB) 宣布计划在未来 12 个月内收购价值 1 亿美元的以太坊
该公司表示，此举将增强其在加密货币投资、药物开发和资产收购等多方面的企业战略
风险提示 风险提示
关联标签
关联标签
扫码下载
BTC $67,358.57 +0.09%
ETH $2,057.29 +0.18%
BNB $592.30 +0.24%
XRP $1.29 -1.54%
SOL $79.62 -1.61%
TRX $0.3189 +0.67%
DOGE $0.0907 -0.93%
ADA $0.2434 -1.01%
BCH $423.46 -4.38%
LINK $8.59 -1.01%
HYPE $35.61 -0.42%
AAVE $91.69 -3.57%
SUI $0.8505 -2.17%
XLM $0.1584 -2.11%
ZEC $241.59 -2.73% BTC $67,358.57 +0.09% ETH $2,057.29 +0.18% BNB $592.30 +0.24% XRP $1.29 -1.54% SOL $79.62 -1.61% TRX $0.3189 +0.67% DOGE $0.0907 -0.93% ADA $0.2434 -1.01% BCH $423.46 -4.38% LINK $8.59 -1.01% HYPE $35.61 -0.42% AAVE $91.69 -3.57% SUI $0.8505 -2.17% XLM $0.1584 -2.11% ZEC $241.59 -2.73%
风险提示 风险提示
ChainCatcher 与创新者共建Web3世界
